Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $167.33.
Several equities analysts recently issued reports on ACLS shares. Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark lowered Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Finally, B. Riley dropped their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd.
Get Our Latest Analysis on Axcelis Technologies
Institutional Inflows and Outflows
Axcelis Technologies Price Performance
ACLS opened at $73.51 on Thursday. The stock’s 50 day simple moving average is $90.57 and its 200 day simple moving average is $110.41. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. Axcelis Technologies has a 1 year low of $69.35 and a 1 year high of $158.61. The firm has a market cap of $2.39 billion, a price-to-earnings ratio of 10.87, a PEG ratio of 2.41 and a beta of 1.60.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Read More
- Five stocks we like better than Axcelis Technologies
- Financial Services Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.